Dr. Jeffrey Hockings is the Founder and CEO of Diabetes Reversal Group (DRG), a healthcare company specializing in clinically reversing type 2 diabetes through a patented, non-drug, natural treatment system. Under Dr. Hockings' leadership, DRG has worked with over 70,000 patients across six countries, boasts the only patented diabetes reversal system in the world, and has a proven 16-year track record backed by thousands of testimonials and an independent study. Dr. Hockings is a board-certified Doctor of Chiropractic, an internationally recognized wellness expert, and has presented more than 430 seminars globally.

In this episode…

Turning real-world experience into something that holds up under scrutiny is challenging. Plenty of ideas work in practice, but very few make the leap into something provable, repeatable, and defensible. So what does it take to transform hands-on results into evidence strong enough to earn a patent?

For Dr. Jeffrey Hockings, the answer starts with relentless testing in the real world. Drawing from his experience as a long-time natural health practitioner, he explains that the breakthrough came from years of refining one system, watching outcomes closely, and removing anything that didn’t consistently work. By treating every patient’s results as data, he built a process that could be documented, defended, and eventually patented. The big lesson is that innovation isn’t just inspiration; it’s discipline applied over time.

In this episode of the Cleinman Connect Podcast, Kim Carson is joined by Dr. Jeffrey Hockings, Founder and CEO of Diabetes Reversal Group (DRG), to discuss turning lived clinical experience into a patented system for reversing type 2 diabetes. They explore why proof matters more than promises, how long-term consistency led to credible results, and what it took to protect the process legally. Dr. Hockings also talks about scaling impact through licensing and partnerships.